Cord Blood S100B Protein Concentration in Neonates With Fetal Growth Restriction

RecruitingOBSERVATIONAL
Enrollment

120

Participants

Timeline

Start Date

June 18, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

March 31, 2026

Conditions
s100bHypoxia-Ischemia, BrainFetal Growth Restriction (FGR)
Interventions
DIAGNOSTIC_TEST

Prenatal ultrasound examination with blood flow analysis

"For all patients who provide informed consent to participate in the study, an ultrasound examination is performed within 48 hours prior to delivery. This assessment includes:~1. Measurement of fetal anthropometric parameters and estimation of fetal weight.~2. Evaluation of blood flow using the pulsatility index (PI) in the UA, UtA, DV, and MCA."

DIAGNOSTIC_TEST

Umbilical cord blood gas analysis

A 0.5 mL blood sample is collected from the clamped section of the umbilical cord and immediately sent to the laboratory for cord blood gas analysis, including the determination of pH, base excess (BE), and lactate levels.

DIAGNOSTIC_TEST

Umbilical cord blood S100B protein level

A 1 mL sample of cord blood is collected in a labeled tube, which includes the mother's name, the child's gender, date of birth, and date of collection. The sample is then sent to the laboratory for centrifugation. The resulting serum samples are frozen, and once approximately 80 samples have been collected, they will be thawed and analyzed for S100B protein concentration. Any remaining material after laboratory processing will be properly disposed of.

DIAGNOSTIC_TEST

Neonatal transfontanelle ultrasound assessment

A transfontanelle ultrasound examination is performed to assess for any abnormalities in the newborn.

Trial Locations (1)

01-211

RECRUITING

Institute of Mother and Child, Warsaw

All Listed Sponsors
lead

Institute of Mother and Child, Warsaw, Poland

OTHER